학술논문
Lutetium-177-DOTA-Rituximab, a new compound for radioimmunotherapy in patients with malignant lymphoma. An interim analyses of a phase I/II study: P875
Document Type
Academic Journal
Author
Source
Onkologie. Oct 01, 2003 26 Suppl 5:175-175
Subject
Language
English
ISSN
0378-584X